Can mirtazapine (Remeron) cause weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine and Weight Gain

Yes, mirtazapine (Remeron) commonly causes weight gain as a side effect. In FDA labeling, increased appetite was reported in 17% of patients treated with mirtazapine compared to 2% for placebo, and weight gain of ≥7% of body weight was reported in 7.5% of mirtazapine-treated patients compared to 0% for placebo 1.

Mechanism and Evidence of Weight Gain

  • Mirtazapine has been consistently associated with increased appetite and weight gain as side effects, which appear to be more common with this medication than with other antidepressants 1, 2
  • In clinical studies, 8% of patients receiving mirtazapine discontinued treatment due to weight gain 1
  • A prospective controlled study found that women taking mirtazapine for 6 weeks experienced significant increases in body weight (from 63.6 kg to 66.6 kg) and fat mass (from 20.9 kg to 22.1 kg) 3
  • Leptin concentrations increased significantly during mirtazapine treatment, which may play a role in the weight gain mechanism 3

Comparative Weight Effects Among Antidepressants

  • Mirtazapine has a higher risk of weight gain compared to many other antidepressants 4, 5
  • Among antidepressants, bupropion is the only one consistently associated with weight loss rather than weight gain 4, 5
  • SSRIs like fluoxetine and sertraline typically cause initial weight loss followed by weight neutrality with long-term use 5
  • Tricyclic antidepressants, particularly amitriptyline, also have a high risk of weight gain 6

Clinical Applications

  • Mirtazapine's weight gain effect has been studied as a potential therapeutic benefit in certain populations:
    • In patients with Alzheimer's disease experiencing weight loss, mirtazapine (30 mg daily) led to weight gain in 77.3% of patients after 3 months (mean gain 1.93 kg) and in 82.3% after 6 months (mean gain 2.11 kg) 7
    • Clinical guidelines note that mirtazapine could potentially play a beneficial role when dementia patients with weight loss and depression require antidepressant treatment 8

Metabolic Considerations

  • Unlike some other medications that cause weight gain, mirtazapine treatment did not significantly affect glucose homeostasis in controlled studies 3
  • However, a study in healthy men showed unfavorable changes in lipid metabolism after 7 days of mirtazapine treatment, including increased triglyceride levels and TG/HDL-C ratio, and decreased HDL-cholesterol 9
  • These lipid changes occurred despite weight loss in the study participants, suggesting direct pharmacological effects on lipid metabolism independent of weight changes 9

Monitoring and Management

  • Regular monitoring of weight is recommended during mirtazapine treatment 1
  • For patients concerned about weight gain, consider:
    • Lifestyle modifications including balanced diet and physical activity 6
    • Alternative antidepressants with more favorable weight profiles if clinically appropriate (e.g., bupropion, fluoxetine, sertraline) 4, 5

Important Caveats

  • Weight gain effects appear to be dose-dependent, with higher doses potentially causing more significant weight gain 2, 10
  • Individual responses to mirtazapine vary, and not all patients will experience significant weight gain 1, 2
  • The sedative effects of mirtazapine may contribute to reduced physical activity, potentially exacerbating weight gain 10

References

Research

Effect of mirtazapine treatment on body composition and metabolism.

The Journal of clinical psychiatry, 2006

Guideline

Weight Gain Associated with Antidepressants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Citalopram and Weight Gain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Weight Gain Associated with Amitriptyline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men.

Naunyn-Schmiedeberg's archives of pharmacology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.